Medizinische Universität Graz - Research portal
SHR
Neuro
Cancer
Cardio
Metab
Microb
Lipid
Nanoscale Functionalities for Targeted Delivery of Biopharmaceuticals
- Abstract
- The present project aims at the development of innovative multidisciplinary approaches for the design, synthesis and evaluation of functionalized nanocarriers and nanoparticle-based microcarriers for the treatment of various diseases based on targeted, controlled delivery of therapeutic peptides and proteins (biopharmaceutics).
The present IP integrates the scientific activities and complementary skills of researchers coming from 13 EU countries and the state of Israel, in an attempt to ensure breakthrough advances in novel biopharmaceutics delivery systems. The Consortium consists of 12 University departments, 6 research institutes, 6 SMEs and 3 large industries. An efficient management scheme has been established to ensure the fulfillment of the IPs scientific, technological and exploitation objectives.
- Local Subprojectlead:
- Pieber Thomas
- Duration:
- 01.10.2006-30.09.2010
- Programme:
- EU (FP-6)
- Subprogramme
- Priority 3: Nanotechnologies and Nanosciences, Knowledge based Mulitfunctional Materials, New Production Processes and Devices
- EU-Project Instruments
- Integrated Project (IP)
- Type of Research
- applied research
- Staff
- Pieber, Thomas, Project Leader
- Missbrenner, Cornelia, Co-worker
- Fröhlich, Eleonore, Co-worker
- Meindl, Claudia, Co-worker
- Heinemann, Akos, Co-worker
- MUG Research Units
- Department of Internal Medicine, Joint Facilities
- Division of Pharmacology
- Project partners
- AplaGen Biopharmaceuticals, Germany
- Center of Molecular and Macromolecular Studies, Poland
- Centre for Research and Technology Hellas/ Chemical Process Engineering Research Institute, Greece
- Chalmers University Gothenburg, Sweden
- Deutsches Wollforschungsinstitut an der RWTH Aachen e.V., Germany
- Ecole Polytechnique Federale de Lausanne, Switzerland
- Glaxo Smith Kline Biologicals, Belgium
- Joanneum Research Forschungsgesellschaft mbH, Austria
- Johannes Gutenberg University, Germany
- Lek Pharmaceuticals, d.d., Slovenia
- Lipoxen Technologies Ltd., United Kingdom
- MagnaMedics GmbH, Germany
- National Centre for Scientific Research "Demokritos", Greece
- National Institute of Chemistry, Slovenia
- NovoNordisk, Denmark
- Regulon A.E., Greece
-
Society for Chemical Engineering and Biotechnology e.V., Germany
Contact person: DR Kurt Wagemann; - SusTech GmbH & Co. KG, Germany
- Tel Aviv University, Israel
- Thiomatrix GmbH, Austria
- Universität Innsbruck, Austria
- Universitat Ramon Llull, Spain
- Université de Liege, Belgium
- Universiteit Maastricht, Netherlands
- University of Trieste, Italy
- University of Twente, Netherlands